Received Mar 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | BL473 | — |
was given the vaccine of the solute, but not of the mixture; was given the vaccine of the solute, but not of the mixture; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 74-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) (batch number BL473, expiry date 13-OCT-2026) for prophylaxis. On 07-MAR-2025, the patient received Arexvy. On 07-MAR-2025, an unknown time after receiving Arexvy, the patient experienced inappropriate preparation of medication (Verbatim: was given the vaccine of the solute, but not of the mixture) and inappropriate dose of vaccine administered (Verbatim: was given the vaccine of the solute, but not of the mixture). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 10-MAR-2025 Reporter stated that they have a resident who gave the vaccine (Arexvy), was given the vaccine of the solute, but not of the mixture, the powder mix which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. So was not reconstituted it and they were wondering what they do now.